List of Tables
Table 1: Global Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 2: Global Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 3: Global Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 4: Global Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 5: Global Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 6: North America Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 7: North America Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 8: North America Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 9: North America Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 10: North America Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 11: Europe Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 12: Europe Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 13: Europe Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 14: Europe Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 15: Europe Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 16: Asia-Pacific Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 17: Asia-Pacific Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 18: Asia-Pacific Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 19: Asia-Pacific Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 20: Asia-Pacific Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 21: Latin America Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 22: Latin America Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 23: Latin America Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 24: Latin America Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 25: Latin America Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 26: Middle East & Africa Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 27: Middle East & Africa Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 28: Middle East & Africa Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 29: Middle East & Africa Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 30: Middle East & Africa Generic Drugs Market Size, By Region, By Value, 2018-2028
Table 31: Teva Pharmaceutical Industries Business Overview
Table 32: Teva Pharmaceutical Industries Financial Analysis
Table 33: Fresenius Kabi Business Overview
Table 34: Fresenius Kabi Financial Overview
Table 35: Sandoz, A Novartis division Business Overview
Table 36: Sandoz, A Novartis division Financial Overview
Table 37: Mylan N.V., Business Overview
Table 38: Mylan N.V., Financial Overview
Table 39: Sanofi S.A., Business Overview
Table 40: Sanofi S.A., Financial Overview
Table 41: Sun Pharmaceutical Industries Limited Business Overview
Table 42: Sun Pharmaceutical Industries Limited Financial Analysis
Table 43: Mallinckrodt Pharmaceuticals Business Overview
Table 44: Mallinckrodt Pharmaceuticals Financial Analysis
Table 45: Stada Arzneimittel AG Business Overview
Table 46: Stada Arzneimittel AG Financial Analysis
Table 47: Aurobindo Pharma Limited Business Overview
Table 48: Aurobindo Pharma Limited Financial Overview
Table 49: Endo International plc., Business Overview
Table 50: Endo International plc., Financial Overview
Table 51: Aspen Pharmacare Holdings Limited Business Overview
Table 52: Aspen Pharmacare Holdings Limited Financial Overview
Table 53: Dr. Reddy's Laboratories Business Overview
Table 54: Dr. Reddy's Laboratories Financial Analysis
Table 55: Cipla Limited Business Overview
Table 56: Cipla Limited Financial Overview
Table 57: Hikma Pharmaceuticals plc., Business Overview
Table 58: Hikma Pharmaceuticals plc., Financial Overview
Table 59: Primal Pharma Solutions Business Overview
Table 60: Primal Pharma Solutions Financial Overview
Table 61: Lupin Limited Business Overview
Table 62: Lupin Limited Financial Overview
Table 63: Sawai Pharmaceutical Co. Ltd., Business Overview
Table 64: Sawai Pharmaceutical Co. Ltd., Financial Overview
Table 65: Amneal Pharmaceuticals, Inc., Business Overview
Table 66: Amneal Pharmaceuticals, Inc. Financial Overview
Table 67: Glenmark Pharmaceuticals Limited Business Overview
Table 68: Glenmark Pharmaceuticals Limited Financial Overview
Table 69: Torrent Pharmaceuticals Ltd., Business Overview
Table 70: Torrent Pharmaceuticals Ltd., Financial Overview
Add to Cart
PDF E-mail From Publisher: $4,250
Show additional purchase options...

Research Assistance
US: 800.298.5699
Int'l: +1.240.747.3093
Live help

Download our eBook: How to Succeed

LIST OF FIGURE

List of Figures
Fig 1: Global Generic Drugs Segmentation
Fig 2: Global Generic Drugs Market Value Chain Analysis
Fig 3: Global Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 4: Global Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 5: Global Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 6: Global Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 7: Global Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 8: Global Generic Drugs Market Share, By Region, By Value, 2018-2028
Fig 9: North America Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 10: North America Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 11: North America Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 12: North America Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 13: North America Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 14: North America Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 15: Europe Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 16: Europe Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 17: Europe Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 18: Europe Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 19: Europe Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 20: Europe Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 21: Asia-Pacific Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 22: Asia-Pacific Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 23: Asia-Pacific Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 24: Asia-Pacific Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 25: Asia-Pacific Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 26: Asia-Pacific Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 27: Latin America Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 28: Latin America Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 29: Latin America Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 30: Latin America Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 31: Latin America Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 32: Latin America Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 33: Middle East & Africa Generic Drugs Market Size, By Value (USD Billion), 2018-2028
Fig 34: Middle East & Africa Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 35: Middle East & Africa Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 36: Middle East & Africa Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 37: Middle East & Africa Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 38: Middle East & Africa Generic Drugs Market Share, By Country By Value, 2018-2028
Fig 39: Company Share Analysis, 2021